| Serial Number | 97412748 |
| Word Mark | APDUCE |
| Filing Date | Monday, May 16, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 26, 2023 |
| Registration Number | 7172959 |
| Registration Date | Tuesday, September 26, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 11, 2023 |
| Goods and Services | Chemical preparations for medical purposes, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs sold in bulk, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; radioactive substances for medical purposes; gases for medical purposes, namely, nitric oxide for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; disinfectants; solutions for contact lenses; media for bacteriological cultures; medicated sweets; dietetic preparations adapted for medical use; depuratives for the body; diagnostic preparations for veterinary purposes; pesticides; sanitary napkins; cotton for medical purposes; dental abrasives; diapers for pets |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, May 27, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ASCENTAGE PHARMA (SUZHOU) CO., LTD. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | JIANGSU 215000 CN |
| Party Name | ASCENTAGE PHARMA (SUZHOU) CO., LTD. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | JIANGSU 215000 CN |
| Party Name | ASCENTAGE PHARMA (SUZHOU) CO., LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | JIANGSU 215000 CN |
| Event Date | Event Description |
| Tuesday, September 26, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, September 26, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 11, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 11, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 21, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, June 5, 2023 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Saturday, May 27, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, May 27, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Saturday, May 27, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Saturday, May 27, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Saturday, May 27, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, April 24, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 24, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 24, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, March 12, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sunday, March 12, 2023 | NON-FINAL ACTION E-MAILED |
| Sunday, March 12, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, March 3, 2023 | ASSIGNED TO EXAMINER |
| Monday, June 27, 2022 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Monday, June 27, 2022 | ASSIGNED TO LIE |
| Tuesday, June 14, 2022 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Monday, May 23, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 19, 2022 | NEW APPLICATION ENTERED |